Pfizer

  • India withdraws regulator's power to cap non-essential drug prices

    NEW DELHI/MUMBAI (Reuters) - India's drug pricing authority said the government has withdrawn its power to set prices of non-essential medicines, but price caps on over 100 non-essential drugs that drew the industry's ire in July will remain. The withdrawal, announced by the authority in a…

    Reuters
  • Germany's Merck to buy Sigma-Aldrich for $17 billion to boost lab supplies operation

    Drugs and chemicals maker Merck KGaA (MRCG.DE) agreed on Monday to acquire U.S.-based Sigma-Aldrich Corp (SIAL.O) for $17 billion (10.41 billion pounds) in cash to boost its lab supplies business, the biggest takeover in the German group's history. The deal helps Merck, 70 percent controlled by the…

    Reuters
  • India withdraws regulator's power to cap nonessential drug prices

    * Ruling does not affect July price caps - official NEW DELHI/MUMBAI, Sept 23 (Reuters) - India's drug pricing authority said the government has withdrawn its power to set prices of nonessential medicines, but price caps on over 100 nonessential drugs that drew the industry's ire in July will…

    Reuters
  • Why Pfizer (PFE) Stock Is Down Today

    also fell 4.63% to $71.21 on Tuesday, as the U.S.-based Pfizer had made a $118 billion bid to acquire its British rival earlier this year. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. "While comprehensive business tax…

    TheStreet.com
  • AstraZeneca Hurt As Obama Tries To Get Tough On Tax Inversions

    The Obama Administration is moving to unilaterally clamp down on U.S. Tuesday evening, the Treasury issued a series of rules meant to make such inversion transactions less attractive, though they won't apply retroactively to existing deals. AstraZeneca dropped 4.5% Tuesday morning, falling along…

    Forbes
  • Shire, AstraZeneca fall in London after U.S. tax move

    Reuters A C D MA MB MC MD ME MP LONDON (MarketWatch) — Shares of Shire PLC and AstraZeneca PLC were under pressure Tuesday, as tax-inversion moves by the U.S. weighed on the merger prospects for the pharmaceutical companies

    MarketWatch
  • Dow Jones (DJIA) Today: Goldman Sachs Group (GS) Leads The Day Higher, Pfizer (PFE) Lags

    Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. The Dow Jones Industrial Average ( ^DJI) is trading down 24.0 points (-0.1%) at 17,148 as of…

    TheStreet.com
  • 3 Stocks Pulling The Drugs Industry Downward

    Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. The Drugs industry currently sits down 2.1% versus the S&P 500, which is down 0.8%. On the negative…

    TheStreet.com